ANIP vs NUVB: stock comparison and AI forecast
Ani Pharmaceuticals Inc (ANIP) and Nuvation Bio Inc. (NUVB) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ANIP Ani Pharmaceuticals Inc
- Market Cap
- $1.66B
- P/E Ratio
- 13.7x
- Size
- small-cap
- AI Forecast
NUVB Nuvation Bio Inc.
- Market Cap
- $1.65B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ANIP and NUVB have similar market capitalizations ($1.66B and $1.65B).
- ANIP turns 734.8% of its revenue into net income, against -88.2% for NUVB.
- NUVB carries 1.93 times debt per unit of equity, against 1.50 times for ANIP.
- ANIP yields 0.02% in dividends; NUVB pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ANIP | NUVB |
|---|---|---|
| Market Cap | $1.66B | $1.65B |
| P/E Ratio | 13.66x | – |
| P/B Ratio | 2.78x | 6.49x |
| Dividend Yield | 0.02% | – |
| EPS | $5.29 | $-0.61 |
| Book Value/Share | $26.01 | $0.72 |
| Revenue/Share | $0.64 | $0.48 |
| FCF/Share | $7.53 | – |
Profitability & Margins
| Metric | ANIP | NUVB |
|---|---|---|
| ROE | 18.1% | -59.0% |
| ROA | 7.2% | -20.1% |
| ROIC | 12.4% | -20.9% |
| Gross Margin | -2528.2% | 92.8% |
| Operating Margin | 1020.0% | -81.0% |
| Net Margin | 734.8% | -88.2% |
| EBT Margin | 967.4% | -88.2% |
| Tax Rate | 24.0% | 0.0% |
Financial Health
| Metric | ANIP | NUVB |
|---|---|---|
| Current Ratio | 2.91x | 8.37x |
| Quick Ratio | 2.41x | 8.14x |
| D/E Ratio | 1.50x | 1.93x |
| Financial Leverage | 2.50x | 2.93x |
| Interest Coverage | 5.4x | -6.8x |
| Working Capital | $542M | $640M |
Cash Flow
| Metric | ANIP | NUVB |
|---|---|---|
| Operating Cash Flow | $189M | -$121M |
| Free Cash Flow | $173M | – |
| Capital Spending | -$16M | – |
| OCF Growth YoY | 36.2% | – |
| FCF Growth YoY | 37.9% | – |
| FCF/Sales | 1173.6% | – |
| CapEx/Sales | 111.8% | – |
Operational Efficiency
| Metric | ANIP | NUVB |
|---|---|---|
| Asset Turnover | 0.01x | 0.23x |
| Receivables Turnover | 0.1x | 6.1x |
| Inventory Turnover | 2.7x | 0.6x |
| Fixed Assets Turnover | 0.2x | 237.6x |
| Days Sales Outstanding | 6797 days | 60 days |
| Days Inventory | 135 days | 594 days |
| Payables Period | 70 days | 361 days |
| Cash Conversion Cycle | 6862 days | 293 days |
Income Statement
| Metric | ANIP | NUVB |
|---|---|---|
| Total Revenue | $15M | $170M |
| Operating Income | $150M | -$138M |
| Net Income | $108M | -$150M |
| R&D Expense | $50M | $129M |
| SG&A Expense | $325M | $159M |
| Cost of Goods Sold | $387M | $12M |
Dividend & Shareholder Information
| Metric | ANIP | NUVB |
|---|---|---|
| Dividends Per Share | $0.01 | – |
| Payout Ratio | 0.2% | – |
| Shares Outstanding | 23M | 351M |
| Net Income Growth | 6358.4% | – |
ANIP vs NUVB: stock comparison and AI forecast
Which is bigger, ANIP or NUVB?
ANIP and NUVB have similar market capitalizations ($1.66B and $1.65B).
Which one does Intratio's AI model rank higher, ANIP or NUVB?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.